BLOG / 🇺🇸 United States · · daily

USA Insider Trading Pulse — June 24, 2026

USA Insider Trading Pulse

By Gunpowder Editorial ·

49 high priority 1 medium priority 50 total filings analysed

Executive Summary

Today's insider trading pulse reveals a market characterized by significant insider selling at high-growth and technology companies, contrasting with selective insider buying in value-oriented and distressed sectors.

Notable large-scale disposals by a 10% owner at Workday ($5.6M), a director at Dell Technologies ($5M), and the President of R&D at Relay Therapeutics ($1.6M) signal potential overvaluation or strategic de-risking at current levels. Conversely, a substantial $8M preferred stock acquisition by a 10% owner at Presurance Holdings and a $1.34M open-market purchase by the Executive Chairman of American Shared Hospital Services indicate strong insider conviction in these specific stories. The data also highlights a wave of director stock awards at CAVA Group, suggesting a focus on long-term alignment. A cluster of insider selling in the biotech sector, particularly at Relay Therapeutics and NewAmsterdam Pharma, warrants caution. Overall, the pattern suggests insiders are taking profits in high-multiple names while deploying capital into perceived undervalued or special situation equities.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: Form 4

Tracking the trend? Catch up on the prior USA Insider Trading Pulse digest from June 23, 2026.

Investment Signals (10)

  • Presurance Holdings ↓ (BULLISH)
    ▲

    A 10% owner acquired $8M in Series D Preferred Stock at $5,000/share, swapping out of Series C. This large, non-dilutive capital injection signals strong insider belief in the company's growth trajectory and potential for a liquidity event.

  • American Shared Hospital Services ↓ (BULLISH)
    ▲

    The Executive Chairman bought $1.34M worth of stock at $2.28, a massive vote of confidence in a micro-cap company. This represents a significant personal investment and suggests the insider sees substantial upside from current levels.

  • Carlyle Tactical Private Credit Fund ↓ (BULLISH)
    ▲

    A major institutional investor, Thrivent Financial, purchased $5M in Mandatory Redeemable Preferred Shares at $25.00. This large, strategic allocation from a sophisticated investor signals confidence in the fund's credit portfolio and yield generation.

  • Workday ↓ (BEARISH)
    ▲

    A 10% owner, David Duffield, sold $5.6M in stock at ~$112.92 as part of a 10b5-1 plan. While pre-planned, the sheer size of the sale and the exercise of 107,500 options for immediate sale creates significant overhead supply and signals a potential top for the stock.

  • Relay Therapeutics ↓ (BEARISH)
    ▲

    The President of R&D sold $1.58M and the CFO sold $1.04M in stock, both via 10b5-1 plans. This coordinated selling by top executives, even if pre-planned, is a strong negative signal for a pre-revenue biotech, suggesting a lack of near-term catalysts or confidence in the stock's valuation.

  • Dell Technologies ↓ (BEARISH)
    ▲

    Director Lynn Vojvodich sold $5.06M in stock at $421 after exercising options at $31.14. This large, profitable sale by a director, even under a 10b5-1 plan, is a bearish signal, indicating a desire to lock in significant gains.

  • Macy's ↓ (BEARISH)
    ▲

    The EVP, COO & CFO sold $409K in stock at $24.89 after exercising options. This sale by a top financial officer, who has the most intimate knowledge of the company's performance, is a bearish signal, especially as the retail sector faces headwinds.

  • Clean Energy Fuels Corp ↓ (BULLISH)
    ▲

    The CEO bought $24.8K in stock at $1.77. While a small absolute amount, an open-market purchase by the CEO in a struggling sector is a contrarian bullish signal, indicating he believes the stock is undervalued at these depressed levels.

  • Ford Motor Co ↓ (BULLISH)
    ▲

    Director John Thornton bought $149K in stock at $14.05. This is a significant open-market purchase by a high-profile director, signaling confidence in Ford's turnaround plan and current valuation.

  • Liquidity Services ↓ (BEARISH)
    ▲

    A director sold $1.46M in stock at $37.99 via a 10b5-1 plan. This large sale by a director, representing a significant portion of his holdings, is a bearish signal, suggesting the stock may be near a peak.

Risk Flags (7)

  • Relay Therapeutics / Insider Exodus↓ [HIGH RISK]
    ▼

    The President of R&D and the CFO both sold large blocks of stock (~$2.6M combined) on the same day. This coordinated insider selling is a major red flag for a clinical-stage biotech, indicating potential data readout concerns or a lack of confidence in the pipeline.

  • Workday / 10% Owner Dumping↓ [HIGH RISK]
    ▼

    David Duffield, a co-founder and 10% owner, sold $5.6M in stock. While under a 10b5-1 plan, the scale of selling by a founder is a significant risk, potentially signaling a long-term shift in sentiment or a belief that the stock's growth is peaking.

  • Macy's / CFO Sells After Options Exercise↓ [HIGH RISK]
    ▼

    The CFO sold over 45% of his exercisable options immediately. This is a classic red flag for a retailer facing structural challenges, suggesting the CFO is not confident in the stock's ability to appreciate further.

  • NewAmsterdam Pharma / CAO Sells Bulk of Holdings↓ [HIGH RISK]
    ▼

    The Chief Accounting Officer sold 39,700 shares, leaving her with only 24,353. This sale of a majority of her stake is a strong negative signal, especially for a pre-revenue biotech, indicating a lack of conviction.

  • Vicor Corp / Director Near-Complete Exit↓ [HIGH RISK]
    ▼

    A director sold all but 100 of his shares after a series of 10 transactions. This near-complete exit by a board member is a severe risk flag, suggesting a fundamental loss of confidence in the company's future.

  • Telos Corp / Director Sells 25% of Stake↓ [MEDIUM RISK]
    ▼

    A director sold 55,772 shares, a significant portion of his holdings, at $4.31. This large sale by a director in a small-cap cybersecurity firm is a bearish signal, potentially indicating headwinds in the business.

  • Jinxin Technology / CFO Sells at $0.24↓ [MEDIUM RISK]
    ▼

    The CFO and COO sold shares at a price of $0.24, near penny stock levels. This sale, while small in value, signals a lack of confidence from top management in a company already trading at distressed levels.

Opportunities (7)

  • American Shared Hospital Services / Insider Confidence↓ (OPPORTUNITY)
    ◆

    The Executive Chairman's $1.34M purchase at $2.28 is a massive vote of confidence. This micro-cap company could be a prime turnaround play if the insider's conviction is justified by upcoming operational improvements or a new strategic direction.

  • Presurance Holdings / Special Situation↓ (OPPORTUNITY)
    ◆

    The $8M preferred stock swap by a 10% owner is a classic catalyst for a special situation. This could be a prelude to a major acquisition, a dividend recap, or a sale of the company. Investors should investigate the terms of the Series D Preferred.

  • Clean Energy Fuels / Contrarian CEO Buy↓ (OPPORTUNITY)
    ◆

    The CEO's open-market purchase at $1.77 is a strong contrarian signal. If the company's fundamentals are bottoming, this could represent a significant buying opportunity before a recovery in the natural gas vehicle fueling sector.

  • Ford Motor / Director Buy at Cycle Low↓ (OPPORTUNITY)
    ◆

    Director John Thornton's $149K purchase at $14.05 is a high-conviction buy from a respected figure. This could signal that Ford's valuation has become attractive, especially with its strong truck franchise and growing EV business.

  • Carlyle Tactical Private Credit Fund / Institutional Endorsement↓ (OPPORTUNITY)
    ◆

    Thrivent Financial's $5M purchase of preferred shares is a strong endorsement of the fund's credit quality and yield. This could attract other institutional investors, providing a floor for the stock.

  • Cencora / Director Buy↓ (OPPORTUNITY)
    ◆

    Director Lauren Tyler bought $149K in stock at $270.23. This open-market purchase by a director in a large-cap pharmaceutical distributor is a bullish signal, suggesting the stock is undervalued relative to its growth prospects.

  • Baozun / CEO Buy at Low Price↓ (OPPORTUNITY)
    ◆

    The CEO bought $28.1K in ADS at $2.81. This is a positive signal for a Chinese e-commerce stock that has been under pressure. The CEO's purchase suggests he believes the worst is over and the stock is undervalued.

Sector Themes (5)

  • Biotech Insider Profit-Taking (CAUTION)
    ◆

    A clear theme of insider selling in the biotech sector, with executives at Relay Therapeutics, NewAmsterdam Pharma, and Zai Lab all selling shares. This suggests a lack of near-term catalysts and a desire to lock in gains after recent rallies, creating a cautious outlook for the sector.

  • Value & Distressed Insider Buying (OPPORTUNITY)
    ◆

    Insiders are deploying capital into value-oriented and distressed names like American Shared Hospital Services, Clean Energy Fuels, and Ford. This contrasts with selling in high-growth tech, indicating a rotation in insider sentiment towards perceived undervaluation.

  • Tech Insider Selling at High Valuations (CAUTION)
    ◆

    Large-scale selling by insiders at Workday, Dell Technologies, and Vicor Corp suggests that technology stocks, particularly those with high valuations, are seen as fully priced by those closest to the business. This is a cautionary signal for the broader tech sector.

  • CAVA Group Director Awards (NEUTRAL)
    ◆

    Five CAVA Group directors were awarded 1,881 shares each in a coordinated grant. This is a standard practice for aligning board interests, but the uniformity and timing suggest a focus on long-term governance and retention rather than any operational signal.

  • Small-Cap Insider Activity Divergence (SELECTIVE)
    ◆

    A divergence is emerging between small-cap stocks where insiders are buying (American Shared, Clean Energy) and those where they are selling (Telos, Jinxin Technology). This suggests a highly selective market where company-specific fundamentals are driving insider behavior.

Watch List (7)

  • Relay Therapeutics / Upcoming Data Readout↓ (HIGH PRIORITY)
    👁

    With top insiders selling heavily, any upcoming clinical data readout will be critical. A negative result could lead to a significant stock decline. Monitor for any news on the RLY-2608 program.

  • Workday / David Duffield's Selling Plan↓ (HIGH PRIORITY)
    👁

    Monitor the remaining sales under David Duffield's 10b5-1 plan. Continued large-scale selling could put persistent downward pressure on the stock.

  • American Shared Hospital Services / Q2 Earnings↓ (MEDIUM PRIORITY)
    👁

    The Executive Chairman's massive buy suggests he expects positive news. The upcoming Q2 earnings call will be crucial to see if the fundamentals justify his conviction.

  • Presurance Holdings / Series D Terms↓ (MEDIUM PRIORITY)
    👁

    The details of the Series D Preferred Stock (conversion price, dividend rate, liquidation preference) are key to understanding the potential upside for common shareholders. File a Form 8-K search for the definitive agreement.

  • Macy's / CFO's Future Sales↓ (MEDIUM PRIORITY)
    👁

    Monitor if the CFO sells his remaining 20,000 shares. A complete exit would be an even stronger bearish signal for the retailer.

  • Clean Energy Fuels / Q2 Volume Report↓ (MEDIUM PRIORITY)
    👁

    The CEO's purchase is a contrarian bet on a recovery. Watch for quarterly volume reports to see if natural gas fueling demand is improving.

  • Ford Motor / EV Strategy Update↓ (MEDIUM PRIORITY)
    👁

    Director Thornton's buy is a vote of confidence in Ford's strategy. Watch for any updates on the company's EV profitability and cost-cutting initiatives.

Filing Analyses (50)
Jinxin Technology Holding Co 4 negative materiality 3/10

24-06-2026

CFO and COO Jiang Jun Jason sold 2 American depositary shares at $0.24 (~$0.48). Jiang Jun Jason holds 2,798,032 shares after the transaction.

  • · CFO and COO Jiang Jun Jason sold 2 American depositary shares at $0.24 (~$0.48)
Amber International Holding Ltd 4 neutral materiality 5/10

24-06-2026

Director IP WING WAI was awarded 1,000 Class A ordinary shares, par value $0.001 per share. IP WING WAI holds 2,000 shares after the transaction.

  • · Director IP WING WAI was awarded 1,000 Class A ordinary shares, par value $0.001 per share
  • · Director IP WING WAI was awarded 1,000 Restricted Stock Units
Seaport Therapeutics, Inc. 4 positive materiality 5/10

24-06-2026

Director HOMBACH ROBERT J. bought 13,000 Common Stock at $18.14 (~$236K). HOMBACH ROBERT J. holds 13,000 shares after the transaction.

  • · Director HOMBACH ROBERT J. bought 13,000 Common Stock at $18.14 (~$236K)
Jiayin Group Inc. 4 neutral materiality 4/10

24-06-2026

Group head of Technology Wang Zhe (Maik) was awarded 160,000 Class A ordinary shares. Wang Zhe (Maik) holds 160,000 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · Group head of Technology Wang Zhe (Maik) was awarded 160,000 Class A ordinary shares
TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD 4 neutral materiality 4/10

24-06-2026

VP Chuang Tzu-Sou gifted 500,000 Common Shares (2330.TW). Chuang Tzu-Sou holds 1,495,165 shares after the transaction.

  • · VP Chuang Tzu-Sou gifted 500,000 Common Shares (2330.TW)
Jiayin Group Inc. 4 neutral materiality 3/10

24-06-2026

Director Xu Yifang was awarded 1,000,000 Class A ordinary shares. Xu Yifang holds 6,454,776 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · Director Xu Yifang was awarded 1,000,000 Class A ordinary shares
Jiayin Group Inc. 4 neutral materiality 4/10

24-06-2026

Chief financial officer Fan Chunlin was awarded 240,000 Class A ordinary shares. Fan Chunlin holds 1,802,152 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · Chief financial officer Fan Chunlin was awarded 240,000 Class A ordinary shares
NuCana plc 4 neutral materiality 5/10

24-06-2026

Director Levy Elliott M. disposed to the issuer 23,811,896 Options.

  • · Director Levy Elliott M. disposed to the issuer 23,811,896 Options
Baozun Inc. 4 positive materiality 4/10

24-06-2026

Chief Executive Officer Qiu Wenbin bought 10,000 American Depositary Shares at $2.81 (~$28.1K). Qiu Wenbin holds 1,623,872 shares after the transaction.

  • · Chief Executive Officer Qiu Wenbin bought 10,000 American Depositary Shares at $2.81 (~$28.1K)
UroGen Pharma Ltd. 4 neutral materiality 5/10

24-06-2026

Director Holden Stuart was awarded 20,000 Stock Option (right ot buy).

  • · Director Holden Stuart was awarded 20,000 Stock Option (right ot buy)
Northwest Bancshares, Inc. 4 neutral materiality 3/10

24-06-2026

Chief Comm. Banking Officer DesMarteau Jacques Marc had withheld for taxes 2,160 Northwest Bancshares, Inc. Common Stock at $14.48 (~$31.3K). DesMarteau Jacques Marc holds 57,242.076 shares after the transaction.

  • · Chief Comm. Banking Officer DesMarteau Jacques Marc had withheld for taxes 2,160 Northwest Bancshares, Inc. Common Stock at $14.48 (~$31.3K)
Carlyle Tactical Private Credit Fund 4 positive materiality 7/10

24-06-2026

THRIVENT FINANCIAL FOR LUTHERANS bought 200,000 Mandatory Redeemable Preferred Shares, Series M at $25.00 (~$5M). THRIVENT FINANCIAL FOR LUTHERANS holds 200,000 shares after the transaction.

  • · THRIVENT FINANCIAL FOR LUTHERANS bought 200,000 Mandatory Redeemable Preferred Shares, Series M at $25.00 (~$5M)
Clean Energy Fuels Corp. 4 positive materiality 4/10

24-06-2026

PRESIDENT AND CEO Corbus Barclay bought 14,000 Common Stock at $1.77 (~$24.8K). Corbus Barclay holds 1,350,021 shares after the transaction.

  • · PRESIDENT AND CEO Corbus Barclay bought 14,000 Common Stock at $1.77 (~$24.8K)
VICOR CORP 4 negative materiality 6/10

24-06-2026

Director D'Amico Andrew sold 300 Common Stock at $357.47 (~$107K). 10 transactions reported in total. D'Amico Andrew holds 100 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · Director D'Amico Andrew exercised/converted 1,216 Common Stock at $32.89 (~$40K)
  • · Director D'Amico Andrew sold 100 Common Stock at $354.12 (~$35.4K)
  • · Director D'Amico Andrew sold 300 Common Stock at $357.47 (~$107K)
  • · Director D'Amico Andrew sold 200 Common Stock at $359.05 (~$71.8K)
  • · Director D'Amico Andrew sold 200 Common Stock at $362.13 (~$72.4K)
  • · Director D'Amico Andrew sold 200 Common Stock at $363.33 (~$72.7K)
  • · Director D'Amico Andrew sold 116 Common Stock at $365.84 (~$42.4K)
  • · Director D'Amico Andrew sold 100 Common Stock at $367.10 (~$36.7K)
Clean Energy Fuels Corp. 4 neutral materiality 4/10

24-06-2026

Chief Operating Officer Frabotta Bartolomeo A. was awarded 50,000 Common Stock. Frabotta Bartolomeo A. holds 512,886 shares after the transaction.

  • · Chief Operating Officer Frabotta Bartolomeo A. was awarded 50,000 Common Stock
Inhibitor Therapeutics, Inc. 4 neutral materiality 4/10

24-06-2026

Director Jerman Michael Allen was awarded 50,000 Common Stock. Jerman Michael Allen holds 180,411 shares after the transaction.

  • · Director Jerman Michael Allen was awarded 50,000 Common Stock
Cencora, Inc. 4 positive materiality 4/10

24-06-2026

Director Tyler Lauren M bought 550 Common Stock at $270.23 (~$149K). Tyler Lauren M holds 4,359 shares after the transaction.

  • · Director Tyler Lauren M bought 550 Common Stock at $270.23 (~$149K)
CAVA GROUP, INC. 4 neutral materiality 4/10

24-06-2026

Director SHAICH RONALD M was awarded 1,881 Common Stock. SHAICH RONALD M holds 9,955 shares after the transaction.

  • · Director SHAICH RONALD M was awarded 1,881 Common Stock
CAVA GROUP, INC. 4 neutral materiality 4/10

24-06-2026

Director WHITE JAMES D was awarded 1,881 Common Stock. WHITE JAMES D holds 7,455 shares after the transaction.

  • · Director WHITE JAMES D was awarded 1,881 Common Stock
FORD MOTOR CO 4 positive materiality 4/10

24-06-2026

Director THORNTON JOHN L bought 10,600 Common Stock, $0.01 par value at $14.05 (~$149K). THORNTON JOHN L holds 486,685 shares after the transaction.

  • · Director THORNTON JOHN L bought 10,600 Common Stock, $0.01 par value at $14.05 (~$149K)
Omada Health, Inc. 4 negative materiality 3/10

24-06-2026

Chief Accounting Officer Gracey Craig sold 2,083 Common Stock at $18.00 (~$37.5K). Gracey Craig holds 7,108 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · Chief Accounting Officer Gracey Craig sold 2,083 Common Stock at $18.00 (~$37.5K)
Workday, Inc. 4 negative materiality 7/10

24-06-2026

10% owner DUFFIELD DAVID A sold 49,759 Class A Common Stock at $112.92 (~$5.62M). 11 transactions reported in total. DUFFIELD DAVID A holds 105,049 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · 10% owner DUFFIELD DAVID A exercised/converted 107,500 Class A Common Stock
  • · 10% owner DUFFIELD DAVID A sold 16,008 Class A Common Stock at $112.08 (~$1.79M)
  • · 10% owner DUFFIELD DAVID A sold 49,759 Class A Common Stock at $112.92 (~$5.62M)
  • · 10% owner DUFFIELD DAVID A sold 6,920 Class A Common Stock at $114.15 (~$790K)
  • · 10% owner DUFFIELD DAVID A sold 7,033 Class A Common Stock at $114.94 (~$808K)
  • · 10% owner DUFFIELD DAVID A sold 3,900 Class A Common Stock at $116.16 (~$453K)
  • · 10% owner DUFFIELD DAVID A sold 10,587 Class A Common Stock at $117.20 (~$1.24M)
  • · 10% owner DUFFIELD DAVID A sold 7,602 Class A Common Stock at $118.15 (~$898K)
Macy's, Inc. 4 negative materiality 6/10

24-06-2026

EVP, COO & CFO Edwards Thomas Jr. sold 16,419 Common Stock at $24.89 (~$409K). Edwards Thomas Jr. holds 20,000 shares after the transaction.

  • · EVP, COO & CFO Edwards Thomas Jr. exercised/converted 36,419 Common Stock
  • · EVP, COO & CFO Edwards Thomas Jr. sold 16,419 Common Stock at $24.89 (~$409K)
  • · EVP, COO & CFO Edwards Thomas Jr. exercised/converted 36,419 Restricted Stock Units
Carlyle Credit Income Fund 4 positive materiality 4/10

24-06-2026

PFO, PAO & Treasurer Joseph Nelson bought 2,000 Common Stock at $2.73 (~$5.46K). Joseph Nelson holds 5,700 shares after the transaction.

  • · PFO, PAO & Treasurer Joseph Nelson bought 2,000 Common Stock at $2.73 (~$5.46K)
AMERICAN SHARED HOSPITAL SERVICES 4 positive materiality 6/10

24-06-2026

Executive Chairman Stachowiak Raymond C bought 586,468 Common Stock No Par Value at $2.28 (~$1.34M). Stachowiak Raymond C holds 586,468 shares after the transaction.

  • · Executive Chairman Stachowiak Raymond C bought 586,468 Common Stock No Par Value at $2.28 (~$1.34M)
LAMAR ADVERTISING CO/NEW 4 neutral materiality 3/10

24-06-2026

Director REIFENHEISER THOMAS V gifted 328 Class A Common Stock. REIFENHEISER THOMAS V holds 44,486 shares after the transaction.

  • · Director REIFENHEISER THOMAS V gifted 328 Class A Common Stock
FVCBankcorp, Inc. 4 neutral materiality 3/10

24-06-2026

Sr EVP, Chief Credit Officer Nassy Michael G. had withheld for taxes 656 Common Stock at $17.24 (~$11.3K). Nassy Michael G. holds 62,534 shares after the transaction.

  • · Sr EVP, Chief Credit Officer Nassy Michael G. had withheld for taxes 656 Common Stock at $17.24 (~$11.3K)
Lifeloc Technologies, Inc 4 positive materiality 4/10

24-06-2026

CEO and President Willkomm Wayne bought 1,300 Common Stock at $2.50 (~$3.25K). Willkomm Wayne holds 41,625 shares after the transaction.

  • · CEO and President Willkomm Wayne bought 1,300 Common Stock at $2.50 (~$3.25K)
Dell Technologies Inc. 4 negative materiality 6/10

24-06-2026

Director Radakovich Lynn Vojvodich sold 12,022 Class C Common Stock at $421.00 (~$5.06M). Radakovich Lynn Vojvodich holds 25,267 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · Director Radakovich Lynn Vojvodich exercised/converted 12,022 Class C Common Stock at $31.14 (~$374K)
  • · Director Radakovich Lynn Vojvodich sold 12,022 Class C Common Stock at $421.00 (~$5.06M)
  • · Director Radakovich Lynn Vojvodich exercised/converted 12,022 Options to Acquire Class C Common Stock
NewAmsterdam Pharma Co N.V. 4 negative materiality 6/10

24-06-2026

Chief Accounting Officer Kooij Louise Frederika sold 39,700 Ordinary Shares at $30.20 (~$1.2M). 6 transactions reported in total. Kooij Louise Frederika holds 24,353 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · Chief Accounting Officer Kooij Louise Frederika exercised/converted 25,000 Ordinary Shares at $10.90 (~$273K)
  • · Chief Accounting Officer Kooij Louise Frederika exercised/converted 15,000 Ordinary Shares at $11.90 (~$179K)
  • · Chief Accounting Officer Kooij Louise Frederika sold 39,700 Ordinary Shares at $30.20 (~$1.2M)
  • · Chief Accounting Officer Kooij Louise Frederika sold 300 Ordinary Shares at $30.73 (~$9.22K)
  • · Chief Accounting Officer Kooij Louise Frederika exercised/converted 25,000 Option (right to buy)
  • · Chief Accounting Officer Kooij Louise Frederika exercised/converted 15,000 Option (right to buy)
Relay Therapeutics, Inc. 4 negative materiality 7/10

24-06-2026

Chief Financial Officer Catinazzo Thomas sold 61,563 Common Stock at $16.97 (~$1.04M). 10 transactions reported in total. Catinazzo Thomas holds 177,461 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · Chief Financial Officer Catinazzo Thomas sold 17,717 Common Stock at $17.01 (~$301K)
  • · Chief Financial Officer Catinazzo Thomas exercised/converted 56,323 Common Stock at $5.04 (~$284K)
  • · Chief Financial Officer Catinazzo Thomas sold 56,323 Common Stock at $16.97 (~$956K)
  • · Chief Financial Officer Catinazzo Thomas exercised/converted 61,563 Common Stock at $5.22 (~$321K)
  • · Chief Financial Officer Catinazzo Thomas sold 61,563 Common Stock at $16.97 (~$1.04M)
  • · Chief Financial Officer Catinazzo Thomas exercised/converted 51,560 Common Stock at $4.45 (~$229K)
  • · Chief Financial Officer Catinazzo Thomas sold 51,560 Common Stock at $16.97 (~$875K)
  • · Chief Financial Officer Catinazzo Thomas exercised/converted 56,323 Stock Option (Right to Buy)
Presurance Holdings, Inc. 4 neutral materiality 6/10

24-06-2026

10% owner Clarkston Companies, Inc. acquired 1,600 Series D Preferred Stock at $5,000.00 (~$8M). Clarkston Companies, Inc. holds 1,600 shares after the transaction.

  • · 10% owner Clarkston Companies, Inc. acquired 1,600 Series D Preferred Stock at $5,000.00 (~$8M)
  • · 10% owner Clarkston Companies, Inc. disposed of 1,600 Series C Preferred Stock at $5,000.00 (~$8M)
BEXIL INVESTMENT TRUST 4 positive materiality 2/10

24-06-2026

WINMILL & CO. INC bought 1,135 Shares of Beneficial Interest at $16.78 (~$19K). WINMILL & CO. INC holds 229,705 shares after the transaction.

  • · WINMILL & CO. INC bought 1,135 Shares of Beneficial Interest at $16.78 (~$19K)
  • · WINMILL & CO. INC bought 1,000 Shares of Beneficial Interest at $16.81 (~$16.8K)
Relay Therapeutics, Inc. 4 negative materiality 6/10

24-06-2026

President, R&D Bergstrom Donald A sold 93,456 Common Stock at $16.94 (~$1.58M). Bergstrom Donald A holds 418,557 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · President, R&D Bergstrom Donald A exercised/converted 93,456 Common Stock at $4.12 (~$385K)
  • · President, R&D Bergstrom Donald A sold 93,456 Common Stock at $16.94 (~$1.58M)
  • · President, R&D Bergstrom Donald A exercised/converted 93,456 Stock Option (Right to Buy)
Zai Lab Ltd 4 negative materiality 4/10

24-06-2026

Director Lis William sold 7,040 American Depositary Shares at $18.09 (~$127K). Lis William holds 50,437 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · Director Lis William sold 7,040 American Depositary Shares at $18.09 (~$127K)
Twist Bioscience Corp 4 negative materiality 2/10

24-06-2026

SVP of Human Resources Green Paula sold 291 Common Stock at $87.32 (~$25.4K). Green Paula holds 120,414 shares after the transaction.

  • · SVP of Human Resources Green Paula sold 291 Common Stock at $87.32 (~$25.4K)
Twist Bioscience Corp 4 negative materiality 2/10

24-06-2026

See Remarks Cho Dennis sold 346 Common Stock at $87.32 (~$30.2K). Cho Dennis holds 119,346 shares after the transaction.

  • · See Remarks Cho Dennis sold 346 Common Stock at $87.32 (~$30.2K)
Arqit Quantum Inc. 4 negative materiality 3/10

24-06-2026

Director Lefebvre d'Ovidio Manfredi sold 492 Business Combination Warrants (right to buy) at $1.80 (~$886).

  • · Director Lefebvre d'Ovidio Manfredi sold 120 Business Combination Warrants (right to buy) at $1.40 (~$168)
  • · Director Lefebvre d'Ovidio Manfredi sold 492 Business Combination Warrants (right to buy) at $1.80 (~$886)
Kornit Digital Ltd. 4 negative materiality 3/10

24-06-2026

Chief Product Officer Gazit Daniel sold 274 Ordinary Shares at $16.70 (~$4.58K). Gazit Daniel holds 2,585 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · Chief Product Officer Gazit Daniel sold 274 Ordinary Shares at $16.70 (~$4.58K)
RIGEL PHARMACEUTICALS INC 4 negative materiality 3/10

24-06-2026

Director Ali-Jackson Kamil sold 2,500 Common Stock at $35.00 (~$87.5K). Ali-Jackson Kamil holds 10,125 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · Director Ali-Jackson Kamil sold 2,500 Common Stock at $35.00 (~$87.5K)
DoorDash, Inc. 4 neutral materiality 4/10

24-06-2026

CHIEF BUSINESS OFFICER Yandell Keith was awarded 37,296 Class A Common Stock. Yandell Keith holds 130,834 shares after the transaction.

  • · CHIEF BUSINESS OFFICER Yandell Keith was awarded 37,296 Class A Common Stock
  • · CHIEF BUSINESS OFFICER Yandell Keith was awarded 12,432 Class A Common Stock
TELOS CORP 4 negative materiality 5/10

24-06-2026

Director Jacobs Bradley W. sold 55,772 Common Stock at $4.31 (~$240K). Jacobs Bradley W. holds 166,612 shares after the transaction.

  • · Director Jacobs Bradley W. sold 55,772 Common Stock at $4.31 (~$240K)
Twist Bioscience Corp 4 negative materiality 4/10

24-06-2026

Chief Executive Officer Leproust Emily M. sold 1,688 Common Stock at $87.32 (~$147K). Leproust Emily M. holds 842,919 shares after the transaction.

  • · Chief Executive Officer Leproust Emily M. sold 1,688 Common Stock at $87.32 (~$147K)
Core Scientific, Inc./tx 4 negative materiality 3/10

24-06-2026

See remarks DUCHENE TODD M sold 7,600 Common Stock at $29.11 (~$221K). DUCHENE TODD M holds 2,048,895 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · See remarks DUCHENE TODD M sold 7,600 Common Stock at $29.11 (~$221K)
  • · See remarks DUCHENE TODD M sold 2,400 Common Stock at $29.88 (~$71.7K)
Imperial Petroleum Inc./Marshall Islands 4 neutral materiality 6/10

24-06-2026

CEO and President Vafias Harry was awarded 440,000 Common Stock. Vafias Harry holds 3,651,506 shares after the transaction.

  • · CEO and President Vafias Harry was awarded 440,000 Common Stock
  • · CEO and President Vafias Harry gifted 33,627 Common Stock
  • · CEO and President Vafias Harry was awarded 299,000 Stock Option (Right to Buy)
LIQUIDITY SERVICES INC 4 negative materiality 6/10

24-06-2026

Director Mateus-Tique Jaime sold 38,471 Common Stock at $37.99 (~$1.46M). Mateus-Tique Jaime holds 164,380 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · Director Mateus-Tique Jaime sold 1,011 Common Stock at $37.95 (~$38.4K)
  • · Director Mateus-Tique Jaime sold 38,471 Common Stock at $37.99 (~$1.46M)
STARWOOD PROPERTY TRUST, INC. 4 neutral materiality 4/10

24-06-2026

CEO, Chairman of the Board STERNLICHT BARRY S disposed of 4,182 Common Stock. STERNLICHT BARRY S holds 3,285,058 shares after the transaction.

  • · CEO, Chairman of the Board STERNLICHT BARRY S disposed of 4,182 Common Stock
CAVA GROUP, INC. 4 neutral materiality 4/10

24-06-2026

Director Shanahan Lauri M was awarded 1,881 Common Stock. Shanahan Lauri M holds 9,955 shares after the transaction.

  • · Director Shanahan Lauri M was awarded 1,881 Common Stock
CAVA GROUP, INC. 4 neutral materiality 3/10

24-06-2026

Director Bosserman David was awarded 1,881 Common Stock. Bosserman David holds 120,918 shares after the transaction.

  • · Director Bosserman David was awarded 1,881 Common Stock
CAVA GROUP, INC. 4 neutral materiality 3/10

24-06-2026

Director Amouyal Philippe was awarded 1,881 Common Stock. Amouyal Philippe holds 19,955 shares after the transaction.

  • · Director Amouyal Philippe was awarded 1,881 Common Stock

Get daily alerts with 10 investment signals, 7 risk alerts, 7 opportunities and full AI analysis of all 50 filings

Start free trial Browse all digests

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: USA Insider Trading Pulse

June 22, 2026

USA Insider Trading Pulse — June 22, 2026

June 18, 2026

USA Insider Trading Pulse — June 18, 2026

June 17, 2026

USA Insider Trading Pulse — June 17, 2026

June 16, 2026

USA Insider Trading Pulse — June 16, 2026

🇺🇸 More from United States

View all →

June 25, 2026

US Pre-Market SEC Filings Roundup — June 25, 2026

US Pre-Market SEC Filings Roundup

June 25, 2026

US Merger & Acquisition SEC Filings — June 25, 2026

US Merger & Acquisition SEC Filings

June 24, 2026

US Pre-Market SEC Filings Roundup — June 24, 2026

US Pre-Market SEC Filings Roundup

June 24, 2026

US Activist Hedge Fund Institutional SEC 13D 13G — June 24, 2026

US Activist Hedge Fund Institutional SEC 13D 13G
← All United States digests